tirzepatide sglt2 Effects of tirzepatide, a dual GIP and GLP-1 receptor agonist, on blood pressure, cardiac function, and sympathetic nervous system in stroke-prone spontaneously hypertensive rats Tirzepatide Surges, Overtakes Older Drugs

The relationship between tirzepatide and GERD is not fully established

Tirzepatide is intended as a long-term treatment for chronic metabolic conditions and should be combined with sustained lifestyle modifications for optimal results

Pyridoxine-related side effects Pyridoxine is generally considered safe when used in low therapeutic doses, as in a compounded formulation

In contrast, certainty of evidence for tirzepatide compared to placebo at the agent-level was consistently low across outcomes, primarily driven by indirect-only evidence and concerns related to transitivity, with additional downgrading for imprecision or heterogeneity in select endpoints (Supplementary Table S25)

Chao et al

Comparable to therapy with GLP-1RA, a stepwise dose escalation starting with a low starting dose was associated with a lower rate of gastrointestinal side effects and better tolerability of tirzepatide (67)